INTRODUCTION

Top Abstract Introduction Materials & Methods Results Discussion References

The failure of cytokine neutralization strategies to protect septic patients from death has heightened interest in the study of receptors that bind lipopolysaccharide (LPS) and LPS-induced macrophage signal transduction (6, 37). An essential LPS signaling pathway remains to be elucidated, however, as redundancy exists at multiple levels. For example, of the LPS receptors, surface expression of CD14 by macrophages confers the greatest sensitivity to LPS (38), and CD14-deficient mice are more resistant to septic shock (15); however, other LPS receptors with more clearly defined signaling capacity exist (23). Subsequent to receptor occupation, multiple signal transduction pathways are activated in LPS-stimulated macrophages. These pathways include the involvement of heterotrimeric and low-molecular-weight G proteins, phospholipases A, C, and D, nonreceptor tyrosine kinases, protein kinase C, and several members of the mitogen-activated protein kinase family leading to enhanced rates of inflammatory mediator transcription and translation (6, 33). In sum, no study to date has demonstrated an absolute requirement for any particular macrophage signal transduction component for LPS-mediated toxicity despite an intense focus on the issue.

Recently, several studies have suggested the existence of a signal transduction component which binds lipid A and is essential to LPS-induced macrophage activation (5, 18, 19). Whether this component is associated with CD14 on the cell surface or is expressed intracellularly remains to be determined. The approach of these previous studies was to use LPS preparations of various biological activities to compare the abilities of these preparations to generate macrophage inflammatory mediators in vitro to their abilities to bind LPS receptors or induce macrophage activation of the transcription factor NF-B. One limitation of these studies, however, was that they could not control for the variability in biological activity of their LPS preparations due to factors such as purity, solubility, and aggregation state. This renders their comparison between in vitro parameters inherently less reliable, particularly with respect to the binding studies. Hence, careful attention to defining the toxicity of an LPS preparation may overcome such concerns by providing an internal control, thus potentially enabling the identification of signal transduction pathways that are induced in macrophages preferentially by toxic species of LPS.

Some data suggest that an important hallmark of LPS-induced macrophage signal transduction is the stimulation of a pathway(s) that ultimately leads to the activation of the transcription factor NF-B (4, 5, 12); however, several lines of evidence to the contrary exist. For example, macrophages derived from an LPS-hyporesponsive strain of mice (C3H/HeJ) activate NF-B without producing tumor necrosis factor alpha (TNF-) or other LPS-induced inflammatory mediators (8). Additionally, NF-B is not required for TNF- transcription (13), and the primary mode of regulation of this cytokine is at a posttranscriptional level (14). To address this issue, we hypothesized that the degree of activation of NF-B by LPS treatment of macrophages in vitro corresponds to the murine lethality of the LPS preparation. We therefore assessed the biological activity of eight preparations of LPS and lipid X and controlled for variation in biological activity due to preparation purity, solubility, and aggregation state by determining the murine 50% lethal dose (LD₅₀) of the stock solutions used for in vitro experiments. Furthermore, we demonstrated the validity of using LPS-treated RAW 264.7 cells for these studies by showing that the production of TNF- and NO by LPS treatment of this cell line predicts endotoxin lethality in mice, particularly when these mediators are analyzed together. Finally, we showed that mobilization of an NF-B-like DNA binding protein in LPS-stimulated RAW cells did not correspond to LPS toxicity. Because exogenous gamma interferon (IFN-), but not ADP, synergized with the nontoxic Rhodobacter capsulatus LPS to induce RAW cell and peritoneal macrophage NO production, we suggest a model whereby toxic preparations of LPS may preferentially activate a signaling pathway leading to the production of a factor that exhibits an IFN--like activity.

	MATERIALS AND METHODS

Top Abstract Introduction Materials & Methods Results Discussion References

Animals and cell culture. Six-week-old male C57Bl/6 mice were purchased from The Jackson Laboratory (Bar Harbor, Maine) and were cared for according to University of Wisconsin School of Medicine and National Institutes of Health guidelines. To obtain resident peritoneal macrophages, mice were sacrificed by cervical dislocation and the abdominal skin was reflected. Hank's buffered salt solution (HBSS) containing 10 U of heparin/ml was injected into the peritoneal cavity (5 ml/mouse), and the mice were shaken for 2 min. Peritoneal cells were collected in a syringe and washed once in HBSS-heparin at 4°C. Erythrocytes were lysed by a 6-min incubation at 4°C in hypotonic Gey's solution (130 mM NH₄Cl, 5 mM KCl, 2 mM Na₂HPO₄, 0.2 mM KH₂PO₄, 5 mM glucose, 25 µM phenol red, 0.2 mM MgCl₂, 25 µM MgSO₄, 0.1 mM CaCl₂, and 1 mM NaHCO₃). Two volumes of medium were added followed by centrifugation at 200 × g for 5 min. The cells were resuspended, plated, and maintained in RPMI 1640 (BioWhittaker, Walkersville, Md.) supplemented with 10% Cosmic calf serum (HyClone Laboratories, Inc., Logan, Utah), 2 mM L-glutamine (BioWhittaker), 2 mM sodium pyruvate, 100 U of penicillin/ml, 100 µg of streptomycin/ml, and 0.25 µg of amphotericin B/ml in a humidified environment at 37°C with 5% CO₂. After 1 h of incubation, the adherent peritoneal cells were washed three times with medium and immediately used for experimentation.

Endotoxins. Eight preparations of LPS were used in this study as well as lipid X, which is a nontoxic lipid A substructure that has LPS-antagonistic properties (27). Phenol-extracted preparations of LPS from Escherichia coli O111:B4, Salmonella minnesota, and Klebsiella pneumoniae were obtained from Sigma (St. Louis, Mo.). The other preparations were generous gifts and included LPS preparations from Neisseria meningitidis A1 (C.-M. Tsai, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Md.), Bacteroides fragilis NCTC 9434 and Pseudomonas aeruginosa PAC 605 (U. Zähringer, Forschungsinstitut, Borstel, Germany), E. coli Re (K. Takayama, William S. Middleton Memorial VA Hospital, Madison, Wis.), R. capsulatus (H. Mayer, Max-Planck Institute, Freiburg, Germany), and synthetic lipid X (P. Stütz, Sandoz, Vienna, Austria). Additionally, synthetic R. capsulatus lipid A was obtained from William Christ (Eisai Research Institute, Andover, Mass.). Pyrogen-free water was used to make a 20 mM HEPES solution at pH 7.4. Each of the LPS preparations was individually resuspended in 20 mM HEPES at a concentration of 10 mg/ml, sonicated, and then diluted to a stock concentration of 0.3 mg/ml in 20 mM HEPES. The level of protein contamination of these stocks was determined by the micro-bicinchoninic acid (BCA) method. Finally, the stock solutions were sonicated again at the beginning of each experiment.

Mass spectrometry. The metal (Mg, Ca, Na, and Fe) and phosphorus contents of the LPS preparations were determined by inductively coupled plasma-mass spectrometry, performed at the University of WisconsinMadison Extension Soil and Plant Analysis Laboratory. After background subtraction, the values reported reflect the metal and phosphorus concentrations (µM) associated with 300 µg of LPS/ml.

LD₅₀ determination. Murine sensitization to LPS was achieved by intraperitoneal injection of D-galactosamine (18 mg in 100 µl of phosphate-buffered saline [PBS]) as described previously (22). Eight twofold serial dilutions of LPS were made for each preparation in PBS. The target LPS concentrations of these dilutions ranged from 12.5 ng/ml to 1.6 µg/ml or from 125 ng/ml to 16 µg/ml, depending on the estimated lethality of the species used. Intravenous injections by the retro-orbital route were performed with a tuberculin syringe, a 25-gauge needle, and a 100-µl injection volume. Mortality was tabulated 48 h postinjection, and all of the mice surviving to this time point lived in good health for at least 1 week until sacrifice. Thirty mice were used per LPS preparation, and the LD₅₀s were determined by the Reed-Muench method (28).

TNF- ELISA. RAW 264.7 cells were plated at 10⁵ cells/well on a 24-well plate for 18 to 24 h and stimulated for 4 h by replacement of the old medium with 400 µl of supplemented RPMI 1640 containing 0 or 1 µg of LPS/ml. Culture supernatants were measured for TNF- content by using a sandwich enzyme-linked immunosorbent assay (ELISA). Briefly, the primary capture antibody, a rat anti-murine TNF- monoclonal antibody (clone MP6-XT22; Pharmingen, San Diego, Calif.), was added to a 96-well Pro Bind ELISA plate (Becton Dickinson, Lincoln Park, N.J.) at a concentration of 1 µg/ml in PBS and incubated overnight at 4°C. After being blocked with 1% bovine serum albumin, the culture supernatants were diluted in PBS, added to the ELISA plate, and incubated for at least 1 h at 37°C. A TNF- standard curve was generated by using a recombinant murine standard (Genzyme, Cambridge, Mass.). Secondary antibodies (rabbit anti-murine TNF- polyclonal antisera; Genzyme) and tertiary antibodies (goat anti-rabbit immunoglobulin G-horseradish peroxidase conjugate; Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.) were plated at 1:1,000 and 1:5,000 dilutions, respectively. Nine 5-min washes with PBS plus 0.02% Tween 20 after the secondary and tertiary antibody incubations consistently resulted in background absorbance readings of less than 0.2 optical density units. Antibody detection involved the use of the TMB Microwell Peroxidase Substrate System (Kirkegaard & Perry, Gaithersburg, Md.) with 1 M H₃PO₄ as the stop reagent and 415 nm as the detection wavelength.

NO assay. RAW 264.7 cells were plated at 10⁵ cells/well (24-well plate) for 18 to 24 h prior to stimulation, whereas peritoneal macrophages were plated at 5 × 10⁵ cells/well for 1 h prior to washing and treatment. Experiments were initiated by replacing the old medium with 400 µl of supplemented RPMI with or without LPS (1 µg/ml) and with or without IFN- (a generous gift of E. Balish, University of Wisconsin, Madison; 20 U/ml for experiments using RAW cells and 1 U/ml for experiments using peritoneal macrophages) followed by incubation at 37°C for 20 h. Nitrite, a stable metabolite of NO, was measured in culture supernatants with the Griess reagent, and concentrations were compared to a standard curve of sodium nitrite, as described previously (7).

Nuclear extract preparation and NF-B electrophoretic mobility shift assay. RAW cells were plated at 2.5 × 10⁶ cells/plate onto 10-cm-diameter petri dishes and incubated for 18 to 24 h prior to the start of the experiment. LPS treatments were performed with 5 ml of fresh medium with or without 1 µg of LPS/ml at 37°C for 1 h. The cells were harvested by being scraped into PBS containing 2% serum and were washed twice with this buffer. Nuclear extracts were prepared as described previously (5). Briefly, cell pellets were resuspended in 400 µl of buffer A containing 10 mM Tris (pH 7.8), 5 mM MgCl₂, 10 mM KCl, 0.3 mM EGTA, 0.3 M sucrose, 10 mM -glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol, 1 µg of aprotinin/ml, and 1 µg of leupeptin/ml. After 15 min of incubation at 4°C, these cells were lysed by adding Nonidet P-40 to a 0.5% final concentration and vortexing for 10 s. Nuclei were harvested by centrifugation at 7,200 × g for 10 s at 4°C. Pellets were then resuspended in 100 µl of buffer B containing 20 mM Tris (pH 7.8), 5 mM MgCl₂, 320 mM KCl, 0.2 mM EGTA, 0.5 mM dithiothreitol, 1 µg of aprotinin/ml, and 1 µg of leupeptin/ml. Supernatants were collected and assayed for protein content by using a standard dye reagent (Bio-Rad, Richmond, Calif.) after centrifugation at 13,500 × g for 15 min at 4°C.

GTPase activity. Plasma membranes were prepared from RAW 264.7 cells by lysis and differential centrifugation (26, 35). GTPase activity was assayed for 5 min at 30°C in the presence of 2 µg of membrane protein, 3 µM ADP, 2 µM [-³²P]GTP, 100 mM (NH₄)₂SO₄, and 5 mM MgCl₂, as described earlier (7, 26, 35).

Statistical analyses. Statistical calculations were generally performed with the software package SPSS v. 6.0 (SPSS Inc, Chicago, Ill.). The production of LPS-induced mediators in vitro is expressed as the mean and standard error from six experiments unless otherwise indicated. Outliers were determined by using the maximum normal residual and the extreme Studentized deviate tests at the 1% level (32). Given the number of LPS species used in this study, Spearman's correlation coefficients were used as a nonparametric test. Comparisons of various in vitro LPS parameters to LD₅₀s were done for only six LPS species because several preparations (P. aeruginosa LPS, R. capsulatus LPS, and lipid X) were not lethal under the conditions initially tested (see Table 1). In contrast, mediator production induced by each of these three species was measurable in vitro; therefore, the comparisons between the levels of TNF- and NO produced by RAW 264.7 cells in response to LPS included all nine of the LPS species tested. One-way analysis of variance and paired Student's t tests were used to determine significant differences in the mediator levels between the treated groups and unstimulated controls. Linear regression was used to generate models of the relationship between TNF- and NO production by LPS-treated macrophages.

	RESULTS

Top Abstract Introduction Materials & Methods Results Discussion References

Characterization of the LPS preparations. We collected the multiple preparations of LPS as lyophilized samples and resuspended them in the same buffer (20 mM HEPES, pH 7.4) with vigorous sonication in order to normalize the biochemical and immunological properties of the vehicle solution. The bioactivity of an LPS preparation is in part due to the chemical structure of its corresponding lipid A molecule, the endotoxic center of LPS (29); hence, the lipid A structures of many of the LPS preparations used in this study are displayed in Fig. 1 for comparison. Because LPS bioactivity can also vary according to purity, solubility, and aggregation state, we set out to characterize some of these parameters before proceeding with the biological studies. For example, the protein content of the individual LPS preparations was determined and was found to be below the detection threshold of the micro-BCA assay. Additionally, because phosphorus and divalent cation contents are thought to influence supramolecular structure and possibly the aggregation state of LPS (17, 30, 34), we quantified these elements in the LPS preparations using mass spectrometry with total sodium and iron contents as controls (Table 1). Despite large variations in ion content, the levels of these ions did not correlate with the biological activity of the LPS preparations with the exception of sodium. In this case, sodium content inversely correlated with the LPS LD₅₀ (Tables 1 and 2) (R_s = 0.94, P = 0.01), although this likely reflects the coincidental contribution of the ion exchange column buffers used in the purification of some of the less toxic LPS samples. Although this analysis does not account for all potential impurities or differences in solubility, etc., we used the same suspension of each LPS preparation for all of the in vivo and in vitro experiments described below, thus eliminating procedural differences that would affect the relative contributions of these aspects which affect bioactivity.

View larger version (26K): [in this window] [in a new window]   FIG. 1.   Species differences in lipid A structure. Previously determined structures are presented for the lipid A molecules of E. coli, S. minnesota, N. meningitidis, B. fragilis, P. aeruginosa, and R. capsulatus (40). Additionally, the structure for lipid X is shown (40). Structural features that have been associated with a reduction in relative biological activity include the lack of a disaccharide or 4' phosphate, the presence of five or fewer fatty acids, the occurrence of branched-chain or unsaturated fatty acids, and fatty acid chain lengths of fewer than 12 carbons (25).

LPS toxicity in mice. To document the biological activities of these LPS preparations, we evaluated the endotoxicities of eight LPS species and lipid X in terms of their individual LD₅₀s in D-galactosamine-sensitized mice. This analysis used 30 mice at 6 weeks of age per LPS species, all of which were treated on the same day. As shown in Table 2, the lethal potencies of these preparations differed by over 160-fold. Under these conditions LPS preparations from smooth Enterobacteriaceae species and N. meningitidis were more toxic than LPS isolated from either B. fragilis or E. coli Re. The LPS preparations from P. aeruginosa and R. capsulatus, as well as that of lipid X, were not lethal in the dilution range tested. In subsequent experiments, the same P. aeruginosa and R. capsulatus LPS preparations proved to be toxic but only at higher doses than those originally tested (i.e., 320 and 1,600 ng, respectively). These data were not included in the LD₅₀ calculations for the preparations of P. aeruginosa and R. capsulatus LPS because they were generated on a different day with a different batch of mice. Lipid X, in subsequent experiments, was not toxic even at dosages of 25 µg/animal.

LPS-induced RAW cell production of TNF- and NO correlates with the LD₅₀ in mice. To determine whether RAW cells were an appropriate cell line in which to test our hypothesis that LPS-stimulated NF-B activation correlates with endotoxicity, we first wanted to demonstrate that the production of NF-B-regulated inflammatory mediators by LPS-treated RAW cells correlated with the LPS LD₅₀. LPS-stimulated macrophage production of TNF- is partially regulated by NF-B (13), and this cytokine is thought to be central to the pathophysiology of endotoxic shock (6). Because this cytokine is produced rapidly upon LPS stimulation of macrophages (11), we measured TNF- production at 4 h in an attempt to maximize differences between the levels produced by toxic and nontoxic species. Using lipid X and the eight LPS preparations in this study, the production of TNF- by RAW 264.7 macrophages treated with LPS ranged from 1.9 ng/ml for E. coli LPS to background levels for lipid X (Fig. 2). These levels of TNF- were found to generally correlate with LPS LD₅₀s (Fig. 2A) (R_s = 0.83, P = 0.04). However, and quite surprisingly, one of the least toxic LPS preparations, i.e., R. capsulatus, induced RAW cells to produce levels of TNF- significantly above that of the unstimulated control or that induced by lipid X (Fig. 2B) (P < 0.01 and P = 0.01, respectively). In fact, the amount of TNF- produced by RAW cells treated with the relatively nontoxic R. capsulatus LPS for 4 h did not differ from the levels induced by the toxic K. pneumoniae LPS (P > 0.50) and was only slightly different from that generated by the highly toxic N. meningitidis LPS (P = 0.10). These results demonstrate that the processes involved in LPS-stimulated macrophage production of TNF- do not completely differentiate between toxic and nontoxic LPS species, suggesting that whereas TNF- may be essential for sepsis pathophysiology, its generation does not completely account for toxicity.

View larger version (15K): [in this window] [in a new window]   FIG. 2.   Correlation of LPS-induced RAW 264.7 macrophage TNF- production to endotoxicity. RAW 264.7 macrophages were plated on a 24-well plate at a density of 105 per well in 1 ml of supplemented RPMI 1640 medium and maintained at 37°C and 5% CO2. The medium was replaced 20 h later with 400 µl of fresh RPMI 1640 medium alone or containing LPS at a final concentration of 1 µg/ml, and the cells were then incubated for 4 h at 37°C. Culture supernatants were diluted 1:10 with PBS and analyzed in triplicate for TNF- content by ELISA (as detailed in Materials and Methods) using a recombinant murine TNF- standard curve and background subtraction. The data are means and standard errors from six cultures for each LPS preparation, with the exception of P. aeruginosa PAC 605 LPS (n = 5). (A) TNF- levels plotted against the LD50 data presented in Table 1. (B) TNF- levels induced by the LPS preparations that were not toxic in the range tested.

View larger version (16K): [in this window] [in a new window]   FIG. 3.   LPS-induced RAW 264.7 cell nitrite production shows some correlation to endotoxin lethality in mice. RAW 264.7 cells were plated and incubated prior to LPS stimulation according to the conditions specified in the legend for Fig. 2. Each of the endotoxins were used to stimulate RAW macrophages for 20 h and were employed at a concentration of 1 µg/ml in 400 µl of supplemented RPMI 1640 medium. Measurement of nitrite levels in the culture supernatants was performed in triplicate with the Griess reagent, as discussed in Materials and Methods. The data are means and standard errors from six cultures treated with each LPS preparation, with the exception of P. aeruginosa PAC 605 LPS (n = 5), and are presented in the same format as in Fig. 2.

View larger version (19K): [in this window] [in a new window]   FIG. 4.   LPS-stimulated TNF- production by RAW cells after 4 h of treatment largely predicts the levels of NO found at 20 h. TNF- levels presented in Fig. 2 are shown plotted against the nitrite data from Fig. 3. Regression analyses of this plot yielded an Rs value of 0.88 (P < 0.01), a positive slope (10 ± 2.2), and an r2 residual value of 0.76.

Mobilization of NF-B is not preferentially induced by toxic species of LPS. Because LPS-stimulated production of both TNF- and NO correlates with the LD₅₀ and is regulated in part by the action of NF-B (13, 39), LPS-stimulated RAW cells are likely to be an appropriate cell line in which to test whether the toxicity of an LPS depends on the ability of the LPS preparation to activate this transcription factor. We therefore measured the capacity of nuclear extract proteins to bind to an oligonucleotide probe consisting of two tandemly repeated copies of the NF-B consensus binding element. After a 1-h LPS stimulation of RAW cells, the nuclear extracts from all of the LPS-treated cultures contained increased levels of NF-B-like DNA binding proteins relative to control samples (Fig. 5A). Densitometric quantification of data from at least three experiments is represented in Fig. 5B. Binding of the probe by these proteins can be prevented by adding a 100-fold excess of unlabeled oligonucleotide, which eliminated labeling of each nuclear extract, thus suggesting saturability. Lipid X was the only preparation that did not appear to mobilize the NF-B-like DNA binding protein(s), consistent with its inability to stimulate RAW cell TNF- and NO production. Of note, R. capsulatus LPS mobilizes this NF-B-like DNA binding protein as efficiently as the highly toxic S. minnesota LPS, suggesting that this parameter alone is not an effective predictor of LPS toxicity.

View larger version (37K): [in this window] [in a new window]   FIG. 5.   R. capsulatus LPS and other LPS preparations except lipid X stimulate nuclear translocation of an NF-B-like DNA binding protein in RAW 264.7 cells. RAW 264.7 cells were plated on 10-cm-diameter dishes at a density of 2.5 × 106/dish 24 h prior to treatment. The conditioned medium was removed and replaced with 5 ml of supplemented RPMI 1640 with and without the indicated endotoxins at a concentration of 1 µg/ml. After 1 h of incubation at 37°C, the cells were harvested and nuclear extracts were prepared as described in Materials and Methods. Nuclear extract protein (5 µg) was incubated with a labeled oligonucleotide containing two tandemly repeated consensus binding elements for NF-B in the presence and absence of a 100-fold excess of unlabeled oligonucleotide. The samples were electrophoresed on a 6% nondenaturing polyacrylamide gel and visualized by autoradiography. (A) A representative experiment is shown. The labeling intensity was quantified by densitometry. (B) Data from panel A represented as the fold stimulation of LPS-induced RAW cell nuclear mobilization of an NF-B-like DNA binding protein relative to that induced by the control medium. The data are means and standard errors from three cultures treated with LPS, with the exception of that for E. coli LPS (n = 4).

R. capsulatus LPS synergizes with IFN-, but not with ADP, to induce NO production. The inability of R. capsulatus LPS to induce RAW cell NO generation, despite its capacity to stimulate RAW cell NF-B-like DNA binding protein mobilization and TNF- production, suggests that R. capsulatus LPS may be able to synergize with secondary inflammatory mediators to induce macrophage NO production. Extracellular adenine nucleotides (e.g., ATP and ADP) are known to act as immune cell mediators, and they are present at inflammatory sites due to cell lysis, platelet aggregation, and release through channels (1, 6, 9). We have previously characterized an LPS-stimulable adenine nucleotide-dependent GTPase activity in RAW cell membranes that appears to be a purinergic receptor-linked G-protein-like activity and that has predicted the ability of various adenine nucleotides to either enhance or inhibit LPS-stimulated macrophage NO production (7, 35). This assay also identified 2-methyl-thio-ATP as a purinergic receptor modulator, and this derivative was subsequently shown to prevent LPS-induced TNF- and IL-1 production as well as endotoxic death in mice (26). Whereas R. capsulatus LPS alone does not stimulate this GTPase, it does synergize with 3 µM ADP to induce a level of RAW membrane GTPase activity that is identical to that of the E. coli LPS control (data not shown). These data suggested that an adenine nucleotide-induced macrophage signal could potentially synergize with R. capsulatus LPS-stimulated NF-B activation to generate RAW cell NO production. As shown in Fig. 6, exogenous ADP does synergize with most of the LPS species examined in terms of RAW macrophage nitrite induction. However, ADP treatment does not enhance the ability of R. capsulatus LPS or lipid X to generate NO (Fig. 6), relative to the ADP-only control, suggesting that the signals induced by extracellular adenine nucleotides cannot potentiate the activity of nontoxic species of LPS.

View larger version (38K): [in this window] [in a new window]   FIG. 6.   ADP cotreatment enhances RAW cell NO production induced by toxic LPS species but not by R. capsulatus LPS. RAW cells were plated and treated according to the conditions described in the legend for Fig. 3. The LPS species were used at a concentration of 1 µg/ml alone or in the presence of 100 µM ADP buffered in 20 mM HEPES, pH 7.4. Data are means and standard errors of nitrite measurements from three separate experiments.

View larger version (34K): [in this window] [in a new window]   FIG. 7.   IFN- cotreatment allows R. capsulatus LPS to induce nitrite production by RAW cells and peritoneal macrophages. (A and B) RAW cells were plated and treated according to the conditions described in the legend for Fig. 3. The LPS species were used at a concentration of 1 µg/ml alone or in the presence of 20 U of IFN-/ml. Where indicated, an aliquot of the R. capsulatus LPS was removed from its stock solution and boiled for 10 min prior to use for stimulating RAW cells. (C) peritoneal cells were plated in 24-well plates at a density of 5 × 105/well and were incubated for 1 h at 37°C. After three washes with medium, these cells were treated with the indicated LPS species (1 µg/ml) with or without 1 U of IFN-/ml for 20 h at 37°C. Data are means and standard errors of nitrite measurements from six (panel A) or three (panels B and C) separate experiments.

	DISCUSSION

Top Abstract Introduction Materials & Methods Results Discussion References

The purpose of this study was to determine whether LPS-induced mobilization of the transcription factor NF-B in macrophages corresponds to LPS toxicity in mice. Our design was to identify an appropriate cell line for these studies while also providing an internal control to eliminate procedural differences that could allow factors such as LPS purity, solubility, and aggregation state to have a dynamic influence on LPS bioactivity. We demonstrate that despite an expected correlation between LPS-stimulated RAW cell production of TNF- and LPS toxicity (Fig. 2), measurements of the in vitro production of this cytokine alone do not completely predict murine lethality. Specifically, the nontoxic preparation of R. capsulatus LPS induced levels of RAW cell TNF- production that were identical to those generated by K. pneumoniae LPS, a preparation at least 30-fold more toxic. Future testing of the serum TNF- levels induced by R. capsulatus LPS in mice might strengthen this assertion; however, similar observations have been made for humans, i.e., the TNF- levels in the sera of septic patients are not predictive of mortality (3). Thus, predictions of LPS toxicity that are based on in vitro cytokine measurements need to include more than just TNF-. In support of this idea, the production of NO by the various LPS preparations was shown to be correlated with LD₅₀ (Fig. 3) and to be strongly correlated with LPS-induced TNF- production (Fig. 4). The mechanisms by which LPS induces the production of these two mediators are at least partially independent because exogenous TNF- alone is unable to stimulate RAW cell NO generation (unpublished data) and the TNF- production induced by R. capsulatus LPS treatment of RAW cells failed to stimulate subsequent NO generation (Fig. 2 and 3). Hence, the combined assessment of LPS-induced RAW cell production of TNF- and NO is the most predictive in vitro indicator of LPS lethality in D-galactosamine-sensitized mice. Moreover, RAW cells are an appropriate cell line for comparing LPS-induced signal transduction events to the endotoxicity of the LPS preparation.

Although the nuclear mobilization of NF-B is rapidly stimulated by LPS treatment of macrophages and provides a useful assay to determine whether transfected LPS receptors are functional, the data in this study show that activation of NF-B is not likely to be the most important hallmark of LPS signal transduction. Specifically, R. capsulatus LPS induced a level of NF-B-like DNA binding protein mobilization similar to that generated by S. minnesota LPS (Fig. 5), despite a greater than 160-fold difference in the murine lethalities of these two preparations (Table 2). This assertion is supported by the fact that multiple immunological and environmental signals that do not mimic septic shock are able to activate NF-B in macrophages and other cell types (20). Additionally, macrophages from an LPS-hyporesponsive strain of mice (C3H/HeJ) can mobilize NF-B in response to LPS treatment and yet do not produce TNF- or other inflammatory mediators in response to LPS treatment (8). One possibility that has been suggested is that activation of NF-B needs to occur for several hours in order to acquire LPS-like effects (36). However, the data in Fig. 5 are consistent with the observations of others who found that R. sphaeroides LPS can induce NF-B nuclear localization and DNA binding capacity for at least 8 h of treatment, which is a period sufficient for iNOS mRNA accumulation in macrophages stimulated by E. coli LPS (21). Collectively, these observations demonstrate that LPS-induced nuclear mobilization of NF-B in macrophages is not sufficient for the production of all LPS-stimulated inflammatory mediators and does not correspond to LPS toxicity.

A separate signal transduction end point and/or pathway that is activated preferentially by toxic species of LPS must, therefore, exist. The ability of R. capsulatus LPS to induce NF-B-like DNA binding protein mobilization and TNF- production while failing to induce nitrite production suggests that iNOS transcription requires a second inflammatory signal that is not generated by nontoxic species of LPS. Extracellular adenine nucleotides were initially hypothesized to provide this signal because R. capsulatus LPS stimulated an adenine nucleotide-dependent G-protein-like activity in RAW cell membranes (data not shown). However, exogenous ADP only synergized with the toxic LPS preparations to induce RAW cell production of NO (Fig. 6B). Because extracellular adenine nucleotides have been shown to have a dramatic impact on LPS-stimulated macrophage TNF-, IL-1, and NO production (7, 26), these data suggest that the ability of extracellular adenine nucleotides to regulate LPS-induced macrophage production of NO may potentially be due to control at a posttranscriptional level.

In contrast, IFN- is known to regulate iNOS expression at the transcriptional level (39), and when added exogenously, this cytokine was able to synergize with R. capsulatus LPS to induce RAW cell production of NO (Fig. 7A). The extent of this synergy was comparable to that facilitated by the toxic LPS preparations. Control experiments showed that this phenomenon was not likely to be due to protein contamination of the R. capsulatus LPS preparation and that synergy also occurred when peritoneal macrophages were treated similarly (Fig. 7B and C). One possibility that these data suggest is that R. capsulatus LPS is unable to induce macrophage iNOS expression because it cannot stimulate macrophages to generate an autocrine factor that exhibits IFN--like activity. IFN- does have an important role in LPS lethality; however, macrophages are thought to be incapable of producing this cytokine (16). Interestingly, two groups have shown that LPS-induced macrophage production of IFN- is necessary and sufficient for NO generation (10, 41); i.e., LPS alone can induce macrophage NO production because of LPS-stimulated generation of endogenous IFN-. Whether LPS-induced macrophage production of IFN- correlates with endotoxicity remains to be determined, however.

In conclusion, this study has shown the importance of determining the lethality of an LPS preparation to provide an internal control for variability in LPS purity, solubility, and aggregation state. Specifically, this approach has allowed us to demonstrate that activation of NF-B and the production of TNF- by LPS treatment of RAW cells can be induced by nontoxic LPS preparations. These data suggest that extreme reductionist models of LPS-induced macrophage signal transduction or septic shock pathogenesis are incomplete. However, the continued use of multiple species of LPS with various biological activities should lead to the identification of other components essential to LPS-stimulated signal transduction and mediator production by macrophages. Finally, because the combined assessment of the production of two or more inflammatory mediators has provided the best models for predicting LPS toxicity in mice (Fig. 4) and humans (3), it is likely that the most effective therapeutics for septic shock will prove to be those which inhibit multiple LPS-induced end points.